Annovis Bio (ANVS) said Thursday it has received a noncompliance notice from the New York Stock Exchange for market capitalization and stockholders' equity both below $50 million for 30 consecutive days.
It has notified the NYSE of its intention to submit a plan within 45 days detailing how it plans to regain listing compliance in the next 18 months, the company said in a statement.
The notice does not impact the company's operations or reporting obligations with the US Securities and Exchange Commission.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。